# Intravitreal Ranibizumab in Retinal Pigment Epithelial Detachments

> **NCT00976222** · PHASE4 · COMPLETED · sponsor: **University Hospital Muenster** · enrollment: 40 (actual)

## Conditions studied

- Pigment Epithelial Detachment

## Interventions

- **DRUG:** intravitreal injection with ranibizumab

## Key facts

- **NCT ID:** NCT00976222
- **Lead sponsor:** University Hospital Muenster
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2014-12
- **Final completion:** 2015-12
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2017-09-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00976222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00976222, "Intravitreal Ranibizumab in Retinal Pigment Epithelial Detachments". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00976222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*